echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > The Instruction of Oxaliplatin

    The Instruction of Oxaliplatin

    • Last Update: 2023-05-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit

    Oxaliplatin is a chemotherapy drug that is used to treat a variety of cancers, including colorectal, ovarian, and lung cancer.
    It is a platinum-based drug that works by damaging the DNA of cancer cells, preventing them from dividing and multiplying.

    The instruction of oxaliplatin involves a number of steps, including preparation, administration, and monitoring of the drug.
    It is important to follow the instructions carefully to ensure the safe and effective use of the drug.

    Before administering oxaliplatin, the healthcare provider will prepare the drug by mixing it with a solution.
    The drug is provided in the form of a powder that is mixed with 500 mL of sodium chloride 0.
    9% injection or 500 mL of dextrose 50% injection.
    The solution is then diluted to a concentration of 5 mg/mL.
    The healthcare provider will also prepare the patient for the administration of the drug by ensuring that they are hydrated and have undergone any necessary pre-treatment procedures.

    Oxaliplatin is administered intravenously (IV), usually over a period of two to three hours.
    The dosage and frequency of the drug will depend on the specific cancer being treated and the patient's individual medical history.
    The healthcare provider will determine the appropriate dosage and administer the drug using an infusion pump.

    After the drug has been administered, the patient will be monitored for any adverse reactions.
    This may include regular blood tests to check the patient's white blood cell count, kidney and liver function, and electrolyte levels.
    The patient may also experience nausea, vomiting, and diarrhea, which can be managed with medication.

    It is important to note that oxaliplatin can cause neurological side effects, including peripheral neuropathy.
    This is a risk that is increased when the drug is given in combination with other chemotherapy drugs, such as irinotecan.
    Peripheral neuropathy can cause numbness, tingling, and pain in the hands and feet, and it can be permanent.
    The healthcare provider will monitor the patient for any signs of peripheral neuropathy and may adjust the dosage or administration of the drug accordingly.

    In conclusion, the instruction of oxaliplatin involves a number of steps, including preparation, administration, and monitoring.
    It is important to follow the instructions provided by the healthcare provider carefully to ensure the safe and effective use of the drug.
    The patient should also be aware of the potential side effects of the drug and report any symptoms immediately to the healthcare provider.

    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.